Earnings Ahead

ALNY - Alnylam Pharmaceuticals, Inc.

188.8 -2.55 -1.33

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

About

Profile


Headquarters

Cambridge, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ALNY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Alnylam posts Q4 topline miss; pushes back key data readout
  • Alnylam Pharmaceuticals Non-GAAP EPS of -$0.77 in-line, revenue of $439.72M misses by $2.58M
  • Alnylam Pharmaceuticals Q4 2023 Earnings Preview
  • Investors growing more bullish on SMID cap biotech stocks
  • Regeneron eyes Wegovy combo to improve quality of weight loss
  • Alnylam reports preliminary Q4 global net product revenues
  • U.S. strong buy ideas for the next 12 months – according to Citi
  • Biotechs post record gains in November amid improving outlook
  • Alnylam reports positive Phase 2 data for hypertension drug
  • Alnylam Pharmaceuticals beats Q3 top and bottom line estimates; updates FY23 outlook
  • Alnylam Pharmaceuticals Q3 2023 Earnings Preview
  • Alnylam downgraded at Oppenheimer ahead of key data readout
  • Alnylam sends Arbutus lower after FDA snub for amyloidosis drug
  • Alnylam U.S. label expansion for amyloidosis drug denied
  • Ionis, AbbVie, Alnylam draw bullish views at Raymond James
  • Citi says concerns over FDA approval of Alnylam drug are "overdone"
  • Alnylam stock falls after FDA panel questions drug's effectiveness
  • Alnylam wins FDA panel backing additional Onpattro indications
  • Alnylam stock trading halted as FDA AdCom meets on amyloidosis drug
  • Alnylam amyloidosis drug led to “small” benefits in Phase 3 trial: FDA
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 -2.16 / -1.56 258.54M / 232.49M Beat!
October 28, 2021 -1.72 / -1.54 187.63M / 218.72M
August 3, 2021 -1.61 / -1.61 220.55M / 192.05M Beat!
April 29, 2021 -1.71 / -1.75 177.57M / 168.5M Beat!
February 11, 2021 -2.09 / -1.78 163.56M / 146.64M Beat!
November 5, 2020 -2.18 / -1.63 125.85M / 119.05M Beat!
August 6, 2020 -1.56 / -1.72 103.96M / 98.76M Beat!
May 6, 2020 -1.62 / -1.89 99.48M / 91.74M Beat!
February 6, 2020 -2.47 / -2.21 71.68M / 71.6M Beat!
October 31, 2019 -1.92 / -2.07 70.06M / 57.17M Beat!
Date Price Open High Low Vol Change
Jan 29 273.99 279.38
279.7
273.45
382K -1.86%
Jan 28 279.19 276.97
283.55
273.33
611K 0.89%
Jan 27 276.73 277.01
287.22
274.24
786K -0.73%
Jan 24 278.76 273.43
279.67
271.52
924K 1.17%
Jan 23 275.54 266.85
277.22
263.01
686K 3.38%
 
Jan 22 266.54 265.71
269.14
262.17
746K 0.58%
Jan 21 264.99 251.37
265.02
251.23
939K 7.60%
Jan 17 246.27 251.28
253.5
245.69
558K -1.16%
Jan 16 249.16 252.54
256.93
247.9
684K -0.74%
Jan 15 251.01 244
255.29
244
871K 4.37%
Jan 14 240.51 258.74
259.6
240.02
784K -6.88%
Jan 13 258.27 240
261.86
236.87
1.2M 8.53%
Jan 10 237.98 237.17
240.16
232.82
706K -1.07%
Jan 8 240.55 236.34
240.65
234.11
654K 1.95%
Jan 7 235.95 234
239.23
232.98
629K 1.20%
Jan 6 233.15 234.09
237.49
231
562K -0.48%
Jan 3 234.28 232.59
235.52
232.35
411K 0.28%
Jan 2 233.62 237.92
239.99
232.25
393K -0.72%
Dec 31, 2024 235.31 237.26
238.44
235.16
370K -0.3%
Dec 30, 2024 236.01 235.73
236.95
233
382K -0.82%
Dec 27, 2024 237.97 241.81
243.61
237.15
343K -1.87%
Dec 26, 2024 242.5 241.78
244.82
240.43
359K -0.31%
Dec 24, 2024 243.25 241.7
243.9
236.7
253K 0.41%
Dec 23, 2024 242.26 244.63
244.64
237.12
718K -1.3%
Dec 20, 2024 245.44 239.45
247.21
235.93
1.7M 2.75%
Dec 19, 2024 238.87 238.11
242.87
233.41
976K 0.40%
Dec 18, 2024 237.92 245.67
247.05
237.25
543K -3.51%
Dec 17, 2024 246.58 242.7
249.58
240.42
634K 1.06%
Dec 16, 2024 243.99 246.44
247.93
242.13
599K -0.59%
Dec 13, 2024 245.44 246.01
249.51
241.89
592K 0.07%
Dec 12, 2024 245.26 255.02
255.47
244.84
751K -3.5%
Dec 11, 2024 254.15 254.5
255.92
250.21
453K 0.09%
Dec 10, 2024 253.91 257.72
257.99
250.33
463K -0.77%
Dec 9, 2024 255.89 255.39
258.12
252.2
611K -0.14%
Dec 6, 2024 256.26 251.6
257.81
250.65
576K 1.77%
Dec 5, 2024 251.81 252.99
255.29
250.21
460K -1.14%
Dec 4, 2024 254.72 250.39
256.68
250.35
422K 1.14%
Dec 3, 2024 251.84 250.59
253.21
247.38
404K -0.46%
Dec 2, 2024 253.01 252.37
255.29
252
511K -0.02%
Nov 29, 2024 253.07 250.59
254.18
250.01
326K -0.26%
Nov 27, 2024 253.74 253.98
256.02
250.27
718K 0.15%
Nov 26, 2024 253.35 249.37
253.74
247.76
986K 0.94%
Nov 25, 2024 250.98 247.36
255.46
247.36
1.2M 2.49%
Nov 22, 2024 244.89 248.9
248.9
243.35
526K -0.77%
Nov 21, 2024 246.8 247.46
250.71
245.32
687K -0.8%
Nov 20, 2024 248.79 235.78
249.1
234.43
1.1M 6.20%
Nov 19, 2024 234.27 232.19
235.94
231.23
831K 0.86%
Nov 18, 2024 232.27 235.8
242.49
229.85
1.6M -1.4%
Nov 15, 2024 235.56 253.11
254.17
234.88
1.8M -8.67%
Nov 14, 2024 257.91 262.18
262.83
256.75
648K -2.53%
Nov 13, 2024 264.6 269.2
271.08
264.31
651K -1.62%
Nov 12, 2024 268.95 268.22
270.77
264.11
1.1M -3.88%
Nov 11, 2024 279.82 276.1
286.58
276.1
907K 0.86%
Nov 8, 2024 277.43 271.63
279.51
270.98
849K 1.91%
Nov 7, 2024 272.22 273.01
275.07
270.04
607K -0.29%
Nov 6, 2024 273.01 266.21
278.21
265.52
1.4M 2.91%
Nov 5, 2024 265.29 268.47
268.89
264.23
970K -1.73%
Nov 4, 2024 269.95 268.82
272.92
263.67
782K -1.45%
Nov 1, 2024 273.91 267.05
274.03
264
866K 2.75%
Oct 31, 2024 266.59 275.41
276
263.65
1.6M 0%